Latest News
MTCI Investigator awarded €6 million funding by the EU to investigate possible treatments for difficult-to-treat types of Breast Cancer.
MTCI investigator successful in EU funded research project to investigate toxicity mechanisms of approved anti-angiogenesis cancer drugs
MTCI Investigator awarded €6 million funding by the EU to investigate possible treatments for difficult-to-treat types of Breast Cancer.
MTCI investigator successful in EU funded research project to investigate toxicity mechanisms of approved anti-angiogenesis cancer drugs
